Long-Term Outcomes of Patients with Epstein-barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in an Expanded Access Program Study

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/1331

Title:	Long-Term Outcomes of Patients with Epstein-barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in an Expanded Access Program Study
Authors:	Prockop, S. Reshaf, R. Tsai, D. Bunin, N. Abu-Arja, R. Mahadeo, K. Weng, W. Van Besien, K. Loeb, D. Nasta, S. D. Nemecek, E. Hiremath, M. Yue, S. Sun, Y. Navarro, W. Nikiforow, S.
Issue Date:	Apr-2020
Journal Volume:	20
Source:	American Journal of Transplantation
URI:	http://scholars.ntou.edu.tw/handle/123456789/1331
ISSN:	1600-6135
Appears in Collections:	河海工程學系

Show full item record

Last Week
0

Last month
0

checked on Oct 13, 2022

Check